Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Rajavtihi Neuronal Adult Stem Cells Project (RNASc)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2009 by Rajavithi Hospital.
Recruitment status was  Not yet recruiting
Rajavithi Biomolecular Research Center
Information provided by:
Rajavithi Hospital Identifier:
First received: June 22, 2009
Last updated: June 23, 2009
Last verified: June 2009
To study the success of Oligodendrocyte progenitor cell culture project in Rajavithi Hospital to identify an unlimited clone human neuronal progenitor stem cells from the human brain in the Biomolecular Research Center. This study aims to produce the reproductive clone of neuronal development protocols and advance projects. Neuronal cells such as pyramidal cells, oligodendrocyte, and dopaminergic neuron differentiation protocol/projects for treatment of Alzheimer's disease, Multiple sclerosis, and Parkinson's disease respectively in next phase of clinical trials.

Condition Intervention Phase
Alzheimer's Disease
Parkinson's Disease
Multiple Sclerosis
Other: Progenitor Stem Cell Culture
Phase 2

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Basic Science
Official Title: Adult Neuronal Progenitor Stem Cell Project

Resource links provided by NLM:

Further study details as provided by Rajavithi Hospital:

Estimated Enrollment: 10
Study Start Date: July 2009
Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   20 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Patients who have elective craniotomy or.
  • Patients who have elective ventriculostomy surgery or.
  • Patients who have elective muscle biopsy or nerve biopsy.
  • Patient who have emergency craniectomy for life threatening from emergency medical and surgical conditions such as Brain herniation or head injury

Exclusion Criteria:

  • Central nervous system infection for example tuberculous or any bacterial infection, Viral infection, fungal infection.
  • Central nervous system Tumor, Malignancy and metastasis.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00927108

Contact: Subsai Kongsaengdao, M.D. +66-86-6596159

Rajavithi Hospital Not yet recruiting
Bangkok, Thailand, 10140
Contact: Susbai Kongsaengdao, M.D.    +66-86-6596159   
Sponsors and Collaborators
Rajavithi Hospital
Rajavithi Biomolecular Research Center
Principal Investigator: Subsai Kongsaengdao, M.D. Rajavithi Hospital
  More Information

Responsible Party: Rajavithi Hospital, Ministry of Public Health Identifier: NCT00927108     History of Changes
Other Study ID Numbers: RH-CMR-005 
Study First Received: June 22, 2009
Last Updated: June 23, 2009
Health Authority: Thailand: Ministry of Public Health

Keywords provided by Rajavithi Hospital:
Adult Progenitor Stem cells
Alzheimer's disease
Parkinson's disease
Multiple sclerosis

Additional relevant MeSH terms:
Multiple Sclerosis
Alzheimer Disease
Parkinson Disease
Demyelinating Autoimmune Diseases, CNS
Autoimmune Diseases of the Nervous System
Nervous System Diseases
Demyelinating Diseases
Autoimmune Diseases
Immune System Diseases
Brain Diseases
Central Nervous System Diseases
Neurodegenerative Diseases
Neurocognitive Disorders
Mental Disorders
Pathologic Processes
Parkinsonian Disorders
Basal Ganglia Diseases
Movement Disorders processed this record on October 27, 2016